Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-09 Purchase | 2021-12-13 8:41 pm | Aeglea BioTherapeutics Inc. | AGLE | Shanafelt Armen Director | 150,000 | $3.6646 | $549,692 | 150,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-08 Option Award | 2022-06-10 8:00 pm | N/A 2032-06-08 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 9:22 pm | N/A 2032-06-06 | Aeglea BioTherapeutics Inc. | AGLE | Shanafelt Armen Director | 43,000 | $0 | 43,000 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 4:30 pm | N/A 2031-06-08 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 17,700 | $0 | 17,700 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-09 5:27 pm | N/A 2031-06-07 | Aeglea BioTherapeutics Inc. | AGLE | Shanafelt Armen Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 4:39 pm | N/A 2030-06-07 | Aeglea BioTherapeutics Inc. | AGLE | Shanafelt Armen Director | 28,100 | $0 | 28,100 (Direct) | View |